Evidence map›Paper›PMID 33066027›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Magnetite-Arginine Nanoparticles as a Multifunctional Biomedical Tool.

Victoria E Reichel, Jasmin Matuszak, Klaas Bente, Tobias Heil, Alexander Kraupner, Silvio Dutz, Iwona Cicha, Damien Faivre

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Whither Magnetic Hyperthermia? A Tentative Roadmap.Materials (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 3 countries.

Victoria E ReichelMax Planck Institute of Colloids and Interfaces, Department of Biomaterials, Am Mühlenberg 1, 14476 Potsdam, Germany.
Jasmin MatuszakSection of Experimental Oncoclogy and Nanomedicine (SEON), ENT Department, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Glückstraße 10a, 91054 Erlangen, Germany.
Klaas BenteMax Planck Institute of Colloids and Interfaces, Department of Biomaterials, Am Mühlenberg 1, 14476 Potsdam, Germany.
Tobias HeilMax Planck Institute of Colloids and Interfaces, Department of Biomaterials, Am Mühlenberg 1, 14476 Potsdam, Germany.
Alexander KraupnernanoPET Pharma GmbH, Luisencarrée Robert-Koch-Platz 4, 10115 Berlin, Germany.ORCID 0000-0003-3609-9906
Silvio DutzInstitute of Biomedical Engineering and Informatics, Technische Universität Ilmenau, PF 100565, 98684 Ilmenau, Germany.ORCID 0000-0002-7258-0943
Iwona CichaSection of Experimental Oncoclogy and Nanomedicine (SEON), ENT Department, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Glückstraße 10a, 91054 Erlangen, Germany.
Damien FaivreMax Planck Institute of Colloids and Interfaces, Department of Biomaterials, Am Mühlenberg 1, 14476 Potsdam, Germany.ORCID 0000-0001-6191-3389
Centre National de la Recherche Scientifique · FRFederal Institute For Materials Research and Testing · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEKurume University · JPMax Planck Institute of Colloids and Interfaces · DENanoPET Pharma (Germany) · DETechnische Universität Ilmenau · DE

Funding

Deutsche Forschungsgemeinschaft FA 835/12-1Max-Planck-Gesellschaft N/ASeventh Framework Programme "NanoAthero" project FP7-NMP-2012-LARGE-6-309820
6 · The paper itself

Abstract

Iron oxide nanoparticles are a promising platform for biomedical applications, both in terms of diagnostics and therapeutics. In addition, arginine-rich polypeptides are known to penetrate across cell membranes. Here, we thus introduce a system based on magnetite nanoparticles and the polypeptide poly-l-arginine (polyR-Fe

Indexed as

hyperthermiairon oxideMRInanoparticletheranostics

Identifiers

PMID33066027
PMCPMC7600042
OpenAlexW3092722440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.